Eli Lilly Abandons Weight Loss Pill Trials!
This episode of On The Pen: The Weekly Dose Podcast breaks down four major stories in obesity medicine: the FDA’s approval of Teva’s so-called “generic” Saxenda at a sky-high price, Wegovy’s accelerated approval in MASH, Novo Nordisk’s headline-grabbing but shaky 57% cardiovascular benefit claim, and Eli Lilly’s decision to scrap its oral GLP-1 naperiglipron. We cut through the spin to ask what these developments really mean for patients fighting for access and better treatment options.
Visit All Our Links
https://linktr.ee/manonthemounjaro
GLP-1 Heart Study
https://onthepen.substack.com/p/new-study-glp-1-drugs-protect-the
As seen on YouTube.
Related in [Weight loss]:
- How To Lose Belly And Thigh Fat Fast | Lose Weight Naturally | Indian Weight Loss Diet By Richa
- Lose 12 Kgs In A Month | Best Diet Plan For Healthy Weight Loss | Fasting |Dr.Manthena’s Health Tips
- உடற்பயிற்சி இல்லாம எடை குறைக்கலாம்? Shocking New Weight Loss Method! No Diet No Exercise Dr. R. Raja
- TRY THIS TEA | WEIGHT LOSS | BOOST METABOLISM | SUPPORTS DIGESTION #shorts #clovebenefits #tea
- How I Lost 15 Kg After Delivery | Weight Loss Program
Other posts:
- New Moon In Libra + Solar Eclipse Yoga | 25 Minutes
- Back Pain Relief Stretches | 10 Min. Yoga For Relaxation & Recovery
- Ukraine Russia War LIVE | 20th Day Of War | Ukraine News | Russia-Ukraine Crisis | Hijab Verdict
- THE BEST UPCOMING MOVIES 2021 & 2022 (New Trailers)
- ALL Star Wars: Skywalker Saga Trailers (1977-2019) | Movieclips Trailers
